ATE507835T1 - C70 fulleren-enthaltendes liposom, verfahren zu seiner herstellung und seine verwendung - Google Patents
C70 fulleren-enthaltendes liposom, verfahren zu seiner herstellung und seine verwendungInfo
- Publication number
- ATE507835T1 ATE507835T1 AT08704499T AT08704499T ATE507835T1 AT E507835 T1 ATE507835 T1 AT E507835T1 AT 08704499 T AT08704499 T AT 08704499T AT 08704499 T AT08704499 T AT 08704499T AT E507835 T1 ATE507835 T1 AT E507835T1
- Authority
- AT
- Austria
- Prior art keywords
- fullerene
- liposome
- production
- containing liposome
- originally
- Prior art date
Links
- 239000002502 liposome Substances 0.000 title abstract 4
- XMWRBQBLMFGWIX-UHFFFAOYSA-N C60 fullerene Chemical compound C12=C3C(C4=C56)=C7C8=C5C5=C9C%10=C6C6=C4C1=C1C4=C6C6=C%10C%10=C9C9=C%11C5=C8C5=C8C7=C3C3=C7C2=C1C1=C2C4=C6C4=C%10C6=C9C9=C%11C5=C5C8=C3C3=C7C1=C1C2=C4C6=C2C9=C5C3=C12 XMWRBQBLMFGWIX-UHFFFAOYSA-N 0.000 title abstract 3
- 229910003472 fullerene Inorganic materials 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 230000000704 physical effect Effects 0.000 abstract 2
- 239000002798 polar solvent Substances 0.000 abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/738—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/81—Preparation or application process involves irradiation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Birds (AREA)
- Nanotechnology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medical Informatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Virology (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007031340 | 2007-02-09 | ||
PCT/JP2008/051928 WO2008096779A1 (ja) | 2007-02-09 | 2008-02-06 | C70含有リポソームおよびその製造方法、並びにその利用 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE507835T1 true ATE507835T1 (de) | 2011-05-15 |
Family
ID=39681685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08704499T ATE507835T1 (de) | 2007-02-09 | 2008-02-06 | C70 fulleren-enthaltendes liposom, verfahren zu seiner herstellung und seine verwendung |
Country Status (6)
Country | Link |
---|---|
US (1) | US8263117B2 (de) |
EP (1) | EP2123288B1 (de) |
JP (1) | JP5334170B2 (de) |
AT (1) | ATE507835T1 (de) |
DE (1) | DE602008006684D1 (de) |
WO (1) | WO2008096779A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5463548B2 (ja) * | 2009-09-08 | 2014-04-09 | 学校法人福岡大学 | 超音波治療用リポソーム及び超音波治療促進用リポソーム |
AU2012217685B2 (en) | 2011-02-15 | 2017-05-18 | Merrimack Pharmaceuticals, Inc. | Compositions and methods for delivering nucleic acid to a cell |
JP2012184199A (ja) * | 2011-03-07 | 2012-09-27 | Nara Institute Of Science & Technology | フラーレン誘導体を用いた水溶性光増感性材料 |
US9685600B2 (en) | 2015-02-18 | 2017-06-20 | Savannah River Nuclear Solutions, Llc | Enhanced superconductivity of fullerenes |
JP6875373B2 (ja) * | 2015-07-22 | 2021-05-26 | 日東電工株式会社 | ナノ粒子凍結乾燥形態のための組成物および方法 |
US10925817B2 (en) | 2016-02-04 | 2021-02-23 | The Cleveland Clinic Foundation | Polyhydroxy fullerene sunscreen active agents and compositions |
CN108904302B (zh) * | 2018-08-02 | 2021-01-29 | 北京福纳康生物技术有限公司 | 水溶性富勒烯外用组合物 |
CN110408272A (zh) * | 2019-07-05 | 2019-11-05 | 浙江大学 | 一种基于主客体作用制备光动力抗菌涂层的方法及其产品和应用 |
US10842742B1 (en) * | 2019-08-08 | 2020-11-24 | Innovation for Success, LLC | Dissolved C60 and method of producing dissolved C60 |
US11400113B2 (en) | 2019-08-08 | 2022-08-02 | Innovation for Success, LLC | Dissolved C60 and method of producing dissolved C60 |
US11484508B2 (en) | 2019-08-08 | 2022-11-01 | Innovation for Success, LLC | Dissolved C60 and method of producing dissolved C60 |
CN113943676A (zh) * | 2021-10-29 | 2022-01-18 | 济南紫金玫瑰股份有限公司 | 一种菌液的培养基 |
CN115040505B (zh) * | 2022-06-24 | 2024-01-30 | 河南科技大学 | 一种光甘草定复合物及其制备方法和应用 |
CN117017795A (zh) * | 2023-08-07 | 2023-11-10 | 浙江理工大学 | 一种双花外泌体富勒烯组合物及其制备方法和用途 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0748302A (ja) | 1993-07-30 | 1995-02-21 | Tokyo Gas Co Ltd | フラロールの合成方法 |
JPH08143478A (ja) | 1994-11-18 | 1996-06-04 | Otsuka Pharmaceut Co Ltd | 磁気共鳴造影剤 |
JPH09235235A (ja) | 1996-02-29 | 1997-09-09 | Res Inst For Prod Dev | 光線力学的治療用フラーレン−水溶性高分子結合体光増感剤 |
JP4291551B2 (ja) | 2002-06-19 | 2009-07-08 | 独立行政法人科学技術振興機構 | ホスト−ゲスト錯体を含有する光電変換素子用材料 |
EP1553924B1 (de) | 2002-06-26 | 2010-12-08 | MediGene AG | Neues verfahren zur stabilisierung von diagnostischen und therapeutischen verbindungen in einem kationischen trägersystem |
JP2004099293A (ja) | 2002-09-12 | 2004-04-02 | Matsushita Electric Ind Co Ltd | 画像形成装置 |
US20060134095A1 (en) * | 2003-01-27 | 2006-06-22 | Shinobu Ito | Antioxidative composition and composition for external use |
JP4360925B2 (ja) | 2003-01-27 | 2009-11-11 | ビタミンC60バイオリサーチ株式会社 | 外用組成物 |
KR100977697B1 (ko) * | 2003-10-10 | 2010-08-24 | 도쿠리쓰교세이호징 가가쿠 기주쓰 신코 기코 | 탄소 화합물이 봉입된 미소 입자의 복합체 |
JP4644430B2 (ja) | 2004-02-10 | 2011-03-02 | 独立行政法人科学技術振興機構 | 炭素化合物の封入された微小粒子の複合体 |
JP2006069812A (ja) | 2004-08-31 | 2006-03-16 | Nara Institute Of Science & Technology | フラーレンの水性化方法 |
JP2006124378A (ja) | 2004-09-29 | 2006-05-18 | Nof Corp | 化粧料用リポソーム |
-
2008
- 2008-02-06 JP JP2008557136A patent/JP5334170B2/ja not_active Expired - Fee Related
- 2008-02-06 WO PCT/JP2008/051928 patent/WO2008096779A1/ja active Application Filing
- 2008-02-06 AT AT08704499T patent/ATE507835T1/de not_active IP Right Cessation
- 2008-02-06 DE DE602008006684T patent/DE602008006684D1/de active Active
- 2008-02-06 US US12/525,977 patent/US8263117B2/en not_active Expired - Fee Related
- 2008-02-06 EP EP08704499A patent/EP2123288B1/de not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
JPWO2008096779A1 (ja) | 2010-05-20 |
EP2123288A1 (de) | 2009-11-25 |
JP5334170B2 (ja) | 2013-11-06 |
EP2123288B1 (de) | 2011-05-04 |
US8263117B2 (en) | 2012-09-11 |
US20100278885A1 (en) | 2010-11-04 |
DE602008006684D1 (de) | 2011-06-16 |
EP2123288A4 (de) | 2010-03-24 |
WO2008096779A1 (ja) | 2008-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE507835T1 (de) | C70 fulleren-enthaltendes liposom, verfahren zu seiner herstellung und seine verwendung | |
ATE506068T1 (de) | Kohlenstoffnanoröhrchenpulver, kohlenstoffnanoröhrchen und verfahren zu ihrer herstellung | |
Shankar et al. | Binding between DNA and carbon nanotubes strongly depends upon sequence and chirality | |
ATE451409T1 (de) | Aminosäurefunktionelle siloxane, herstellungsverfahren und anwendungen | |
ATE520427T1 (de) | Poröse intravaskuläre embolisierungsteilchen und verfahren zu deren herstellung | |
ATE435256T1 (de) | Verfahren zur herstellung von kationisch stabilisierten und in wasser redispergierbaren polymerpulverzusammensetzungen | |
ATE447593T1 (de) | Niedrigviskose uretdiongruppenhaltige polyadditionsverbindungen, verfahren zur herstellung und verwendung | |
WO2007025861A3 (de) | Modifizierte kohlenstoff-nanopartikel, verfahren zu deren herstellung und deren verwendung | |
BRPI0908450A2 (pt) | Vetor para transformação usando transposons, micro-organismos transformados pelo vetor e método para produzir l-lisina usando o mesmo | |
DE602007013512D1 (de) | Verfahren zur kontinuierlichen Herstellung von Bauteilen | |
DE502006007528D1 (de) | Verfahren zur kontinuierlichen Herstellung von Kohlenstofffasern | |
ATE413875T1 (de) | Zusammensetzungen enthaltend levetiracetam und verfahren zu deren herstellung. | |
DE602006004911D1 (de) | Gasphasenoxidationskatalysator und dessen Verwendung zur Herstellung von Acrylsäure | |
EP2557123A4 (de) | Polycarbonatharzzusammensetzung, verfahren zu ihrer herstellung und formartikel aus dieser harzzusammensetzung | |
ATE501114T1 (de) | Herstellung von 3-pentennitril aus 1,3-butadien | |
DE602008006188D1 (de) | 7-alkynyl-1,8-naphthyridon-derivate, verfahren zu ihrer herstellung und ihre verwendung für therapeutika | |
ATE477798T1 (de) | Verwendung von agomelatin zur herstellung von medikamenten zur behandlung der generalisierten angststörung | |
EP2121877A4 (de) | Integrierte mehrstufige superkritische technologie zur herstellung hochqualitativer pflanzenöle und biokraftstoffe | |
DE502006005961D1 (de) | Endoskop und Verfahren zu seiner Herstellung | |
ATE537817T1 (de) | Nanoteilchen-träger zur verabreichung von arzneimitteln und verfahren zu ihrer herstellung | |
EP2199778A4 (de) | Sediment zur spektrometrie, verfahren zur herstellung davon und spektroskopisches verfahren | |
ATE509923T1 (de) | Derivate von 7-alkynyl-1,8-naphthyridonen, verfahren zu ihrer herstellung und ihre verwendung in therapeutika | |
WO2008121850A3 (en) | Small-molecule modulators of melanin expression | |
MX354780B (es) | Compuesto imida, metodo para fabricarlo y su uso como insecticida. | |
ATE510818T1 (de) | Kohlensäure- und schwefelsäuresalze von 3-(2,2,2- trimethylhydrazinium)propionatestern und deren verwendung zur herstellung von 3-(2,2,2- trimethylhydrazinium)propionat-dihydrat |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |